Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

True outcomes for patients on antiretroviral therapy who are "lost to follow-up" in Malawi.

Yu JK, Chen SC, Wang KY, Chang CS, Makombe SD, Schouten EJ, Harries AD.

Bull World Health Organ. 2007 Jul;85(7):550-4.

2.

Evaluation of a workplace HIV treatment programme in South Africa.

Charalambous S, Innes C, Muirhead D, Kumaranayake L, Fielding K, Pemba L, Hamilton R, Grant A, Churchyard GJ.

AIDS. 2007 Jul;21 Suppl 3:S73-8.

PMID:
17666964
3.

A program to provide antiretroviral therapy to residents of an urban slum in nairobi, kenya.

Marston BJ, Macharia DK, Nga'nga L, Wangai M, Ilako F, Muhenje O, Kjaer M, Isavwa A, Kim A, Chebet K, Decock KM, Weidle PJ.

J Int Assoc Physicians AIDS Care (Chic). 2007 Jun;6(2):106-12.

PMID:
17538002
4.

Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa.

Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R.

AIDS Care. 2007 May;19(5):658-65.

PMID:
17505927
5.

Risk factors for treatment denial and loss to follow-up in an antiretroviral treatment cohort in Kenya.

Karcher H, Omondi A, Odera J, Kunz A, Harms G.

Trop Med Int Health. 2007 May;12(5):687-94.

6.

Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya.

Hawkins C, Achenbach C, Fryda W, Ngare D, Murphy R.

J Acquir Immune Defic Syndr. 2007 Jul 1;45(3):304-10.

PMID:
17414931
7.

Implementation of an antiretroviral access program for HIV-1-infected individuals in resource-limited settings: clinical results from 4 African countries.

Sow PS, Otieno LF, Bissagnene E, Kityo C, Bennink R, Clevenbergh P, Wit FW, Waalberg E, Rinke de Wit TF, Lange JM; Cohort Program to Evaluate Access to Antiretroviral Therapy and Education Project Team.

J Acquir Immune Defic Syndr. 2007 Mar 1;44(3):262-7.

PMID:
17146376
8.

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators.

Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, Wu P, Wilson K, Buchan I, Gill CJ, Cooper C.

PLoS Med. 2006 Nov;3(11):e438. Review.

9.

Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi.

Zachariah R, Teck R, Buhendwa L, Fitzerland M, Labana S, Chinji C, Humblet P, Harries AD.

Trans R Soc Trop Med Hyg. 2007 Jan;101(1):79-84. Epub 2006 Sep 8.

PMID:
16962622
10.

Lessons learned from a paying antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experience.

Hosseinipour MC, Neuhann FH, Kanyama CC, Namarika DC, Weigel R, Miller W, Phiri SJ.

J Int Assoc Physicians AIDS Care (Chic). 2006 Sep;5(3):103-8.

PMID:
16928878
11.

Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.

Lawn SD, Myer L, Harling G, Orrell C, Bekker LG, Wood R.

Clin Infect Dis. 2006 Sep 15;43(6):770-6. Epub 2006 Aug 8.

12.

Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M.

JAMA. 2006 Aug 16;296(7):782-93.

PMID:
16905784
13.

Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.

Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, Rachlis B, Wu P, Cooper C, Thabane L, Wilson K, Guyatt GH, Bangsberg DR.

JAMA. 2006 Aug 9;296(6):679-90. Review.

PMID:
16896111
14.

Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.

Nachega JB, Hislop M, Dowdy DW, Lo M, Omer SB, Regensberg L, Chaisson RE, Maartens G.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):78-84.

PMID:
16878045
15.

Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector.

Bisson GP, Frank I, Gross R, Lo Re V 3rd, Strom JB, Wang X, Mogorosi M, Gaolathe T, Ndwapi N, Friedman H, Strom BL, Dickinson D.

AIDS. 2006 Jun 12;20(9):1333-6.

PMID:
16816566
16.

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.

Etard JF, Ndiaye I, Thierry-Mieg M, Guèye NF, Guèye PM, Lanièce I, Dieng AB, Diouf A, Laurent C, Mboup S, Sow PS, Delaporte E.

AIDS. 2006 May 12;20(8):1181-9.

PMID:
16691070
17.
18.

Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment.

Ferradini L, Jeannin A, Pinoges L, Izopet J, Odhiambo D, Mankhambo L, Karungi G, Szumilin E, Balandine S, Fedida G, Carrieri MP, Spire B, Ford N, Tassie JM, Guerin PJ, Brasher C.

Lancet. 2006 Apr 22;367(9519):1335-42.

PMID:
16631912
19.

Supervision, monitoring and evaluation of nationwide scale-up of antiretroviral therapy in Malawi.

Libamba E, Makombe S, Mhango E, de Ascurra Teck O, Limbambala E, Schouten EJ, Harries AD.

Bull World Health Organ. 2006 Apr;84(4):320-6. Epub 2006 Apr 13.

20.

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries.

Braitstein P, Brinkhof MW, Dabis F, Schechter M, Boulle A, Miotti P, Wood R, Laurent C, Sprinz E, Seyler C, Bangsberg DR, Balestre E, Sterne JA, May M, Egger M; Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration; ART Cohort Collaboration (ART-CC) groups.

Lancet. 2006 Mar 11;367(9513):817-24. Erratum in: Lancet. 2006 Jun 10;367(9526):1902.

PMID:
16530575
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk